The COVID-19 pandemic is caused by a newly discovered coronavirus, SARS-CoV-2. To characterize and detect this new virus, antibodies to support scientific research, diagnosis and vaccine development are in urgent need. Sino Biological, Inc. develops specific S and N antibodies to SARS-CoV-2 by several antibody generation platforms, including hybridoma, B cell antibody cloning and antibody phage display library. Meanwhile, we also obtained antibodies to recognize all 7 strains of coronaviruses that infected humans. Several candidates are selected for further analysis in research, potential diagnosis applications, and to facilitate vaccine development.

Learning Objectives:

1. Applications of SARS-CoV-2 antibodies

2. Strategies and technology platforms for developing SARS-CoV-2 antibodies

3. Challenges and case studies of SARS-CoV-2 antibody generation